Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Axios
Axios
Health

Pfizer, Moderna vaccines 94% effective in preventing hospitalization in adults 65 and older

The Pfizer and Moderna vaccines were 94% effective in preventing hospitalization for COVID-19 among adults 65 years and older, according to a study by the Centers for Disease Control and Prevention.

Why it matters: The research, which studied 417 hospitalized adults in 14 states between January and March, adds real-world evidence from the clinical trials that vaccination protects against severe illness and hospitalization.


  • "These data suggest that continuing to rapidly vaccinate U.S. adults against COVID-19 will likely have a marked impact on COVID-19 hospitalization and might lead to commensurate reductions in post-COVID conditions and deaths," the report reads.

The state of play: Fully vaccinated individuals showed a 94% efficacy rate. Those who only had one dose had an effectiveness of 64%.

  • Older adults that contract COVID-19 are at a higher risk of getting severely ill, being hospitalized and dying, which is why it's important to increase vaccination efforts, the agency says.

Yes, but: The study also showed no significant vaccine effectiveness less than 14 days after the first dose of a vaccine, showing the importance of immunity build and continued use of social distancing measures and face coverings.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.